N
Noris Pavía-Ruz
Researcher at National Autonomous University of Mexico
Publications - 20
Citations - 2296
Noris Pavía-Ruz is an academic researcher from National Autonomous University of Mexico. The author has contributed to research in topics: Reactogenicity & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 9, co-authored 19 publications receiving 2244 citations.
Papers
More filters
Journal ArticleDOI
Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis
Guillermo M. Ruiz-Palacios,Irene Pérez-Schael,F. Raúl Velázquez,Hector Abate,Thomas Breuer,Sue Ann Costa Clemens,Brigitte Cheuvart,Felix Espinoza,Paul Gillard,Bruce L. Innis,Yolanda Cervantes,Alexandre da Costa Linhares,Pio Lopez,Mercedes Macias-Parra,Eduardo Ortega-Barria,Vesta Richardson,Doris Maribel Rivera-Medina,Luis Rivera,Belén Salinas,Noris Pavía-Ruz,Jorge Salmerón,Ricardo Rüttimann,Juan Carlos Tinoco,Pilar Rubio,Ernesto Nuñez,M. Lourdes Guerrero,Juan Pablo Yarzabal,Silvia Damaso,Nadia Tornieporth,Xavier Sáez-Llorens,Rodrigo Vergara,Timo Vesikari,Alain Bouckenooghe,Ralf Clemens,Beatrice De Vos,Miguel O'Ryan +35 more
TL;DR: Two oral doses of the live attenuated G1P[8] HRV vaccine were highly efficacious in protecting infants against severe rotavirus gastroenteritis, significantly reduced the rate of severe gastroenteropathy from any cause, and were not associated with an increased risk of intussusception.
Journal ArticleDOI
Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.
Alexandre da Costa Linhares,F. Raúl Velázquez,Irene Pérez-Schael,Xavier Sáez-Llorens,Hector Abate,Felix Espinoza,Pio Lopez,Mercedes Macias-Parra,Eduardo Ortega-Barria,Doris Maribel Rivera-Medina,Luis Rivera,Noris Pavía-Ruz,Ernesto Nuñez,Silvia Damaso,Guillermo M. Ruiz-Palacios,Beatrice De Vos,Miguel O'Ryan,Paul Gillard,Alain Bouckenooghe +18 more
TL;DR: Two doses of RIX4414 were effective against severe rotavirus gastroenteritis during the first 2 years of life in a Latin American setting and inclusion of Rix4414 in routine paediatric immunisations should reduce the burden of rotav virus gastroEnteritis worldwide.
Journal ArticleDOI
Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial
Juan Carlos Tinoco,Noris Pavía-Ruz,Aurelio Cruz-Valdez,Carlos Aranza Doniz,Vijayalakshmi Chandrasekaran,Walthère Dewé,Aixue Liu,Bruce L. Innis,Varsha K. Jain +8 more
TL;DR: Immunogenicity of QIV lots was consistent, QIV was superior to TIV for the alternate B-lineage strain, andQIV was non-inferior versus TIVs for shared strains (A/H1N1, A/H3N2, B-strain).
Journal ArticleDOI
[Oral Candida in Mexican children with malnutrition, social marginalization, or HIV/AIDS].
Luis Alberto Gaitán-Cepeda,Luis Octavio Sánchez-Vargas,Noris Pavía-Ruz,Rocío Muñoz-Hernández,Julio Villegas-Ham,Alejandro Caballos-Salobreña +5 more
TL;DR: Los infantes con inmunodeficiencia y con desnutricion requieren de estrategias disenadas para disminuir the colonizacion bucal candidal y disminUir el riesgo of infecciones oportunistas.
Journal ArticleDOI
A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age.
Noris Pavía-Ruz,Miguel Angel Rodriguez Weber,Yu-Lung Lau,E. Anthony S. Nelson,Angkool Kerdpanich,Li-Min Huang,Peter E. Silas,Paul Qaqundah,Mark M. Blatter,Robert Jeanfreau,Paul Lei,Varsha K. Jain,Mohamed El Idrissi,Yang Feng,Bruce L. Innis,Mathieu Peeters,Jeanne-Marie Devaster +16 more
TL;DR: In children aged 6–35 months, immune responses with Flu-50 fulfilled regulatory criteria but did not meet the pre-defined criteria for non-inferiority vs. control, and Reactogenicity/safety endpoints were within the same range for all vaccines.